Lamotrigin Orifarm

Lamotrigine, the active ingredient in Lamotrigin Orifarm, is an anticonvulsant presented as a tablet for oral use. It is indicated for the treatment of epilepsy, for maintenance therapy in bipolar disorder, and for the prevention of migraine attacks in adult patients, and is widely prescribed worldwide.

GNH USA supplies Lamotrigin Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company continually adheres to stringent quality standards and provides reliable sourcing for global healthcare providers.

Lamotrigin Orifarm (lamotrigine) is used in neurological and psychiatric conditions where abnormal neuronal excitability is a key factor.

- Epilepsy: reduces seizure frequency and severity in patients with various seizure types. - Bipolar disorder: stabilizes mood and prevents recurrence of depressive or manic episodes. - Migraine prevention: decreases the frequency of migraine attacks in adults.

Lamotrigin Orifarm may cause a range of adverse reactions.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate pain in the head region. - Nausea: feeling of stomach upset or urge to vomit. - Rash: skin irritation that may appear as redness or small bumps. - Blurred vision: temporary visual disturbances. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering and mucosal involvement. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Aseptic meningitis: inflammation of the meninges without bacterial infection. - Blood dyscrasias: rare blood disorders such as agranulocytosis. - Hepatic failure: severe liver injury requiring medical attention.

When prescribing Lamotrigin Orifarm, several safety considerations are recommended.

- Dose titration: increase the dose gradually to lower the risk of rash. - Skin reactions: monitor patients closely for any rash, especially during the first weeks of therapy. - Hepatic impairment: adjust dosing in patients with liver disease. - Concomitant valproate: avoid high‑dose combinations as they markedly raise lamotrigine levels. - Pregnancy: use only if the therapeutic benefit outweighs potential risks; data are limited. - Store at room temperature: keep below 25°C in the original packaging, protect from moisture.

Lamotrigin Orifarm can interact with several medicines; awareness of major and moderate interactions helps maintain safety.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine plasma concentrations. - Carbamazepine: reduces lamotrigine levels, potentially decreasing efficacy. - Phenobarbital: lowers lamotrigine concentrations, risking loss of seizure control.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may lower lamotrigine levels; monitor seizure frequency. - Serotonergic agents: combined use can increase the risk of serotonin syndrome. - Other antiepileptic drugs: may require dose adjustments based on therapeutic response.